Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.807 | 0.280 | 6 | 30311353 | intron variant | G/A | snv | 6.6E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 2 | 2009 | 2012 | |||||||
|
1.000 | 0.120 | 6 | 30307469 | intron variant | G/T | snv | 0.66 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 2 | 2007 | 2009 | |||||||
|
6 | 30305977 | non coding transcript exon variant | TTTT/-;TTT;TTTTT;TTTTTT;TTTTTTTTT | delins |
|
0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||||
|
1.000 | 0.080 | 6 | 30311297 | intron variant | C/G | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.080 | 6 | 30315875 | intron variant | G/C | snv |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.120 | 6 | 30289159 | non coding transcript exon variant | C/T | snv | 0.13 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | |||||||
|
1.000 | 0.120 | 6 | 30289159 | non coding transcript exon variant | C/T | snv | 0.13 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.120 | 6 | 30289159 | non coding transcript exon variant | C/T | snv | 0.13 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.120 | 6 | 30302303 | non coding transcript exon variant | G/A | snv | 0.28 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.040 | 6 | 30314555 | intron variant | T/C | snv | 0.92 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.807 | 0.280 | 6 | 30311353 | intron variant | G/A | snv | 6.6E-02 |
|
0.700 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.807 | 0.280 | 6 | 30311353 | intron variant | G/A | snv | 6.6E-02 |
|
0.700 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.807 | 0.280 | 6 | 30311353 | intron variant | G/A | snv | 6.6E-02 |
|
Neoplasms; Immune System Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.807 | 0.280 | 6 | 30311353 | intron variant | G/A | snv | 6.6E-02 |
|
0.700 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.807 | 0.280 | 6 | 30311353 | intron variant | G/A | snv | 6.6E-02 |
|
Infections; Immune System Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.807 | 0.280 | 6 | 30311353 | intron variant | G/A | snv | 6.6E-02 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.807 | 0.280 | 6 | 30311353 | intron variant | G/A | snv | 6.6E-02 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.807 | 0.280 | 6 | 30311353 | intron variant | G/A | snv | 6.6E-02 |
|
0.700 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.807 | 0.280 | 6 | 30311353 | intron variant | G/A | snv | 6.6E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
6 | 30308903 | intron variant | TTTT/-;T;TT;TTT;TTTTT;TTTTTT;TTTTTTTTTTTTTTTT | delins |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
1.000 | 0.120 | 6 | 30317344 | intron variant | C/T | snv | 0.33 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.120 | 6 | 30306684 | non coding transcript exon variant | A/G | snv | 0.32 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 |